Literature DB >> 4069160

Percutaneous catheter commissurotomy in rheumatic mitral stenosis.

J E Lock, M Khalilullah, S Shrivastava, V Bahl, J F Keane.   

Abstract

We attempted percutaneous transcatheter-balloon mitral commissurotomy in eight children and young adults (9 to 23 years of age) with rheumatic mitral stenosis. The atrial septum was traversed by needle puncture, and an 8-mm angioplasty balloon was advanced over a guide wire. The atrial septal perforation was then dilated to allow passage of the valvuloplasty balloon catheter (18 to 25 mm) across the mitral annulus. Inflation of the transmitral balloon decreased the end-diastolic transmitral gradient temporarily in all patients (from 21.2 +/- 4.0 mm Hg [mean +/- S.D.] to 10.1 +/- 5.5 mm Hg; P less than 0.001). The immediate decrease in the gradient was associated with increases in cardiac output (from 3.8 +/- 1.0 to 4.9 +/- 1.3 liters per minute per square meter of body-surface area; P less than 0.01) and in the calculated mitral-valve-area index (from 0.73 +/- 0.29 to 1.34 +/- 0.32 cm2 per square meter; P less than 0.001). Murmur intensity diminished immediately after commissurotomy in all patients. The greatest reduction in pressure gradient (76 to 95 per cent) occurred when the largest balloon (inflated diameter, 25 mm) was used in the smallest patients (0.9 to 1.2 m2). The balloon commissurotomy produced minimal mitral regurgitation in only one child. Follow-up catheterization (at two to eight weeks) demonstrated persistence of hemodynamic improvement with evidence of partial restenosis in one patient. These early results indicate that balloon mitral commissurotomy can be a safe and effective treatment for children and young adults with rheumatic mitral stenosis.

Entities:  

Mesh:

Year:  1985        PMID: 4069160     DOI: 10.1056/NEJM198512123132405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  The changing role of the cardiac catheterization laboratory.

Authors:  R D Leachman; W E Dear; E Garcia
Journal:  Tex Heart Inst J       Date:  1988

Review 2.  Therapeutic cardiac catheterization in children.

Authors:  J D Waldman; R E Swensson
Journal:  West J Med       Date:  1990-09

3.  Magnetic resonance evaluation of mitral stenosis.

Authors:  J H Park; M C Han; B H Oh; J G Im; S H Kim
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Oct-Nov       Impact factor: 2.740

4.  Real-time MRI guided atrial septal puncture and balloon septostomy in swine.

Authors:  Amish N Raval; Parag V Karmarkar; Michael A Guttman; Cengizhan Ozturk; Ranil Desilva; Ronnier J Aviles; Victor J Wright; William H Schenke; Ergin Atalar; Elliot R McVeigh; Robert J Lederman
Journal:  Catheter Cardiovasc Interv       Date:  2006-04       Impact factor: 2.692

Review 5.  Percutaneous approaches to valvular heart disease.

Authors:  Peter C Block; Philipp Bonhoeffer
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

6.  Significance of commissural calcification on outcome of mitral balloon valvotomy.

Authors:  N Sutaria; D B Northridge; T R Shaw
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

7.  The relief of mitral stenosis. An historic step in cardiac surgery.

Authors:  M N Khan
Journal:  Tex Heart Inst J       Date:  1996

8.  History of Cardiology in India.

Authors:  Mrinal Kanti Das; Soumitra Kumar; Pradip Kumar Deb; Sundeep Mishra
Journal:  Indian Heart J       Date:  2015-05-21

9.  Patient profile and results of percutaneous transvenous mitral commissurotomy in mitral restenosis following prior percutaneous transvenous mitral commissurotomy vs surgical commissurotomy.

Authors:  Kamal H Sharma; Sharad Jain; Anand Shukla; Shomu Bohora; Bhavesh Roy; Gaurav D Gandhi; A J Ashwal
Journal:  Indian Heart J       Date:  2013-12-22

10.  Percutaneous transarterial balloon dilatation of the mitral valve: five year experience.

Authors:  U U Babic; S Grujicic; Z Popovic; Z Djurisic; P Pejcic; M Vucinic
Journal:  Br Heart J       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.